Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAPN1 | P07384 | 8/20 | 0.61 |
| ▸ | CTSB | P07858 | 3/20 | 0.54 |
| ▸ | RAMP3 | O60896 | 12/20 | 0.44 |
| ▸ | CALCR | P30988 | 12/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3871588 | 0.89 | CAPN1 (0.53) | CAPN1CTSB | |
| SCHEMBL29379569 | 0.81 | CAPN1 (0.62) | CAPN1CTSBRAMP3CALCR | |
| SCHEMBL30544033 | 0.79 | CAPN1 (0.48) | CAPN1RAMP3CALCR | |
| SCHEMBL30518982 | 0.79 | CAPN1 (0.53) | CAPN1CTSBRAMP3CALCR | |
| SCHEMBL31603948 | 0.79 | CAPN1 (0.54) | CAPN1CTSBRAMP3CALCR | |
| SCHEMBL29630674 | 0.76 | CAPN1 (0.53) | CAPN1CTSB | |
| SCHEMBL29876639 | 0.76 | CAPN1 (0.62) | CAPN1CTSB | |
| SCHEMBL31226653 | 0.76 | XIAP (0.56) | CAPN1CTSB | |
| SCHEMBL29576210 | 0.76 | CAPN1 (0.55) | CAPN1CTSB | |
| SCHEMBL30610253 | 0.76 | CAPN1 (0.61) | CAPN1CTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8962697-B2 | Bioreponsive polymers | INTERFACE BIOLOGICS INC. (CA) | 2015-02-24 | — | — | US | disclosed |
| US-20100041771-A1 | Bioreponsive Polymers | INTERFACE BIOLOGICS, INC. | 2010-02-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100041771-A1 | Bioreponsive Polymers | PEPD, PREP, DNPEP | CAPN1 1234/4885CTSB 75/4885RAMP3 1357/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.